Načítá se...
VHL and Hypoxia Signaling: Beyond HIF in Cancer
Von Hippel-Lindau (VHL) is an important tumor suppressor that is lost in the majority of clear cell carcinoma of renal cancer (ccRCC). Its regulatory pathway involves the activity of E3 ligase, which targets hypoxia inducible factor α (including HIF1α and HIF2α) for proteasome degradation. In recent...
Uloženo v:
| Vydáno v: | Biomedicines |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874692/ https://ncbi.nlm.nih.gov/pubmed/29562667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines6010035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|